Stockscreener 앱 받기
15.76
5.14%
0.77
시간 외 거래:
15.80
0.04
+0.25%
전일 마감가:
$14.99
열려 있는:
$15.4
하루 거래량:
2.02M
Relative Volume:
1.44
시가총액:
$1.53B
수익:
$221.08M
순이익/손실:
$-2.92M
주가수익비율:
315.20
EPS:
0.05
순현금흐름:
$5.89M
1주 성능:
+6.78%
1개월 성능:
+41.35%
6개월 성능:
+100.25%
1년 성능:
+7.76%
1일 변동 폭
$15.12
$15.78
1주일 범위
$14.21
$15.78
52주 변동 폭
$6.38
$16.66
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
명칭
Avadel Pharmaceuticals Plc
전화
636-449-1830
주소
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
AVDL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
15.76 | 1.46B | 221.08M | -2.92M | 5.89M | 0.05 |
|
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-03 | 개시 | Wells Fargo | Equal Weight |
| 2025-07-18 | 재개 | H.C. Wainwright | Buy |
| 2025-02-11 | 개시 | Deutsche Bank | Buy |
| 2024-06-12 | 개시 | Rodman & Renshaw | Buy |
| 2024-03-05 | 재확인 | H.C. Wainwright | Buy |
| 2024-03-05 | 재확인 | Needham | Buy |
| 2024-03-05 | 재확인 | Oppenheimer | Outperform |
| 2024-02-06 | 개시 | UBS | Buy |
| 2022-11-30 | 업그레이드 | Jefferies | Hold → Buy |
| 2022-08-10 | 다운그레이드 | Jefferies | Buy → Hold |
| 2022-07-28 | 재개 | Craig Hallum | Buy |
| 2022-05-26 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-09-23 | 개시 | Needham | Buy |
| 2020-07-31 | 개시 | Oppenheimer | Outperform |
| 2020-07-21 | 개시 | SVB Leerink | Outperform |
| 2020-06-30 | 개시 | H.C. Wainwright | Buy |
| 2020-04-03 | 개시 | Jefferies | Buy |
| 2020-03-12 | 개시 | Stifel | Buy |
| 2020-02-26 | 개시 | Piper Sandler | Overweight |
| 2020-01-30 | 개시 | Craig Hallum | Buy |
| 2019-06-14 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
모두보기
Avadel Pharmaceuticals Plc 주식(AVDL)의 최신 뉴스
Will Avadel Pharmaceuticals plc continue its uptrendStop Loss & Free Weekly Watchlist of Top Performers - Newser
Is Avadel Pharmaceuticals plc a candidate for recovery playJuly 2025 EndofMonth & Reliable Volume Spike Trade Alerts - Newser
What is the earnings history of Avadel Pharmaceuticals plc2025 Key Lessons & Detailed Earnings Play Strategies - خودرو بانک
Smart tools for monitoring Avadel Pharmaceuticals plc’s price actionQuarterly Trade Review & Weekly Market Pulse Updates - Newser
Is a relief rally coming for Avadel Pharmaceuticals plc holdersCEO Change & Daily Profit Maximizing Tips - Newser
Will Avadel Pharmaceuticals plc benefit from macro trendsPortfolio Update Report & Advanced Swing Trade Entry Alerts - Newser
Avadel Pharmaceuticals at Wells Fargo Conference: Strategic Growth and Challenges - Investing.com UK
Avadel Pharmaceuticals Presents 17 Abstracts on LUMRYZ Efficacy at World Sleep 2025, Highlighting Benefits of Once-Nightly Sodium Oxybate for Narcolepsy Treatment - Quiver Quantitative
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025 - The Manila Times
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025 - GlobeNewswire Inc.
Predicting Avadel Pharmaceuticals plc trend using moving averagesJuly 2025 Sector Moves & Real-Time Market Sentiment Alerts - Newser
Is Avadel Pharmaceuticals plc stock ready for a breakout2025 Market Outlook & Reliable Breakout Forecasts - Newser
Applying Elliott Wave Theory to Avadel Pharmaceuticals plcJobs Report & High Accuracy Swing Entry Alerts - Newser
Tick level data insight on Avadel Pharmaceuticals plc volatilityWeekly Volume Report & Daily Price Action Insights - Newser
Published on: 2025-09-04 22:28:10 - Newser
The Once-Nightly, Salt-Free, Artificial Sweetener-Free Oxybate in the Works for Narcolepsy, IH - Sleep Review
Avadel Pharmaceuticals plc Testing Reversal Zone on Weekly ChartDividend Hike & Free Fast Entry Momentum Trade Alerts - beatles.ru
Avadel Pharmaceuticals (AVDL) Attracts Institutional Investment - MSN
Why Avadel Pharmaceuticals plc is moving todayJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - Newser
Avadel secures rights to develop valiloxybate globally - Pharmaceutical Technology
Sleep Disorder Market Heats Up with Avadel’s Global Grab for Valiloxybate - geneonline.com
Avadel licenses once-at-bedtime oxybate therapy from XWPharma By Investing.com - Investing.com Canada
Will Avadel Pharmaceuticals plc rebound enough to break evenJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - Newser
Can you recover from losses in Avadel Pharmaceuticals plcWeekly Loss Report & Low Drawdown Investment Ideas - Newser
How to read the order book for Avadel Pharmaceuticals plcTrade Risk Report & Weekly Sector Rotation Insights - Newser
Avadel licenses once-at-bedtime oxybate therapy from XWPharma - Investing.com
Avadel: XWPharma to receive $20m upfront - AInvest
Avadel Pharmaceuticals gets Valiloxybate license from XWPharma - AInvest
Avadel Pharmaceuticals Licenses Valiloxybate from XWPharma for Sleep Treatments. - AInvest
Avadel Pharmaceuticals and XWPharma Enter Exclusive License Agreement for Valiloxybate, a Novel Once-at-Bedtime Oxybate for Sleep Disorders - Quiver Quantitative
Avadel Pharmaceuticals Strengthens Sleep Medicine Portfolio with Exclusive License of Valiloxybate from XWPharma Ltd - The Manila Times
Salt-Free Sleep Drug Deal: Avadel Pharma Expands Portfolio with $20M Valiloxybate License for Narcolepsy - Stock Titan
Is Avadel Pharmaceuticals plc currently under institutional pressureJuly 2025 Recap & Reliable Breakout Stock Forecasts - خودرو بانک
Wells Fargo Initiates Avadel Pharmaceuticals at Equalweight With $16 Price Target - MarketScreener
Is now a turning point for Avadel Pharmaceuticals plcMarket Activity Summary & Breakout Confirmation Trade Signals - Newser
Avadel Pharmaceuticals plc stock chart pattern explained2025 Market Outlook & AI Forecast Swing Trade Picks - Newser
Sector ETF performance correlation with Avadel Pharmaceuticals plcWeekly Volume Report & Weekly High Conviction Ideas - Newser
Can Avadel Pharmaceuticals plc continue delivering strong returnsForecast Cut & Smart Investment Allocation Insights - خودرو بانک
Custom watchlist performance reports with Avadel Pharmaceuticals plcJuly 2025 Short Interest & Proven Capital Preservation Methods - Newser
Will Avadel Pharmaceuticals plc outperform the marketPortfolio Gains Summary & Accurate Trade Setup Notifications - Newser
What earnings revisions data tells us about Avadel Pharmaceuticals plcJuly 2025 Momentum & Fast Gain Swing Alerts - Newser
Is now the right time to enter Avadel Pharmaceuticals plcMarket Volume Summary & Real-Time Market Sentiment Alerts - خودرو بانک
Pullback Watch: Is Avadel Pharmaceuticals plc exposed to political riskMarket Activity Summary & High Return Trade Guides - خودرو بانک
Can Avadel Pharmaceuticals plc benefit from deglobalizationQuarterly Performance Summary & Community Driven Trade Alerts - خودرو بانک
Avadel Pharmaceuticals plc (AVDL)’s LUMRYZ™ Sales Surge 64% in Breakout Quarter - MSN
Is Avadel Pharmaceuticals plc stock good for income investors2025 Macro Impact & Real-Time Chart Breakout Alerts - خودرو بانک
How to use a screener to detect Avadel Pharmaceuticals plc breakoutsWeekly Trade Review & Accurate Intraday Trade Tips - Newser
Avadel Pharmaceuticals Plc (AVDL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Avadel Pharmaceuticals Plc 주식 (AVDL) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Thornton Peter J. | Director |
Jan 13 '25 |
Buy |
8.04 |
10,000 |
80,450 |
104,055 |
| Ende Eric J | Director |
Jan 13 '25 |
Buy |
7.84 |
30,000 |
235,218 |
208,900 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 13 '24 |
Buy |
10.44 |
2,300 |
24,019 |
87,800 |
| MCHUGH THOMAS S | Chief Financial Officer |
Dec 11 '24 |
Buy |
10.49 |
5,000 |
52,432 |
85,500 |
| Divis Gregory J | Chief Executive Officer |
Dec 06 '24 |
Buy |
9.98 |
9,598 |
95,759 |
9,598 |
| Divis Gregory J | Chief Executive Officer |
Dec 09 '24 |
Buy |
9.82 |
402 |
3,948 |
10,000 |
| Glass Geoffrey Michael | Director |
Dec 10 '24 |
Buy |
9.84 |
20,279 |
199,641 |
75,904 |
| Palczuk Linda | Director |
Dec 06 '24 |
Buy |
10.19 |
3,000 |
30,568 |
66,400 |
3.53%
자본화:
|
볼륨(24시간):